Olaparib combined with abiraterone in HRR-mutated metastatic hormone-sensitive prostate cancer: a single-arm phase II trial

World Journal of Urology 2026

View at publisher

Authors: Xuyu Zhang, Zhigang Wu, Lingling Hao, Xuefeng Qiu, Linfeng Xu, Shun Zhang, HongQian Guo, Junlong Zhuang

DOI: 10.1007/s00345-026-06460-8

Cited by: 1

References: 30

Fields of Study & Subjects

Prostate Cancer Treatment and Research PARP inhibition in cancer therapy Prostate Cancer Diagnosis and Treatment

References 30